BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Prevnar 13 regulatory update

Pfizer submitted applications to FDA and the European Medicines Agency (EMA) to expand the label for Prevnar 13 to include the prevention of disease caused by 13 serotypes of Streptococcus pneumoniae in adults aged 50 years and...

Read the full 161 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >